2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid,
elafibranor,
GFT505,
Elafibranor,
923978-27-2,
GFT505,
GFT-505,
UNII-2J3H5C81A5,
GFT 505,
2J3H5C81A5,
(E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoic acid,
824932-88-9,
(E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-enyl)phenoxy)-2-methylpropanoic acid,
Elafibranor [INN],
Elafibranor [USAN],
Elafibranor(GFT505),
GFT-505;Elafibranor,
SureCN815512,
SCHEMBL815512,
CHEMBL3707395,
SCHEMBL16552997,
EX-A757,
BCP19067,
MFCD27987940,
AKOS027325486,
ZINC114643710,
ACN-036974,
CS-5522,
DB05187,
SB16790,
HY-16737,
J-690356,
2-(2,6-Dimethyl-4-(3-(4-(methylsulfanyl)phenyl)-3-oxoprop- 1-en-1-yl)phenoxy)-2-methylpropanoic acid,
2-[2,6-dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methylpropanoic acid,
Propanoic acid, 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propen-1-yl)phenoxy)-2-methyl-,
CID9864881,
CID 9864881,
A15454,
(4S)-2-{2-Hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl}-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid,